What do HTA agencies need for generating health-related quality of life evidence? Findings from a global survey
Authors:
- Annushiah Vasan ThakumarATAnnushiah Vasan Thakumar
- Paula LorgellyPLPaula Lorgelly
- Louise LongworthLLLouise Longworth
- Lucila Rey-AresLRLucila Rey-Ares
- Fredrick PurbaFPFredrick Purba
- Dominik GolickiDGDominik Golicki
- Federico AugustovskiFAFederico Augustovski
- Kim RandKRKim Rand
- Rosalie VineyRVRosalie Viney
- Nick BansbackNBNick Bansback
- Nan LuoNLNan Luo
Open Access
- 27 February 2026
- journal article
- method
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 42 (1) , 1-29
Abstract
Objectives: The overall aim is to understand the practices, views, and needs of health technology assessment (HTA) practitioners worldwide regarding the use of health-related quality of life (HRQoL) data for generating cost-effectiveness evidence. Methods: We invited HTA practitioners in sixty countries to complete an online survey on their perspectives on the measurement and valuation of health. We performed descriptive analyses of the overall sample, examined response differences across six regions, and pooled responses to open-ended questions for content analysis. Results: A total of 238 individuals from 45 countries completed the survey, with a mean response number per country of 5.28 (SD: 4.45). Most responses came from public sector employees (seventy-two percent), and ninety percent were involved in cost-effectiveness-related work. The top three most frequently used utility instruments were EQ-5D, SF-6D, and EQ-5D-Y, and the elicitation methods were time trade-off, visual analogue scale, and standard gamble. Health-state preferences of the general public from another country were more frequently used than the preferences of the local public. Common data quality issues were poor sample representativeness and a small sample size of utility data. In Asia and Western Europe, the top-voted research priority was developing utility instruments that capture both healthcare and social care impact. In four regions, developing utility instruments for children was the second-highest research priority. Conclusions: The survey addressed important knowledge gaps regarding current practices in measuring and valuing HRQoL in HTA and provided insights into HTA practitioners’ views on instruments, methods, and data-related challenges and needs for generating HRQoL evidence.Keywords
This publication has 34 references indexed in Scilit:
- Are Current Reporting Standards Used to Describe Health State Utilities in Cost-Effectiveness Models Satisfactory?Value in Health, 2020
- The ‘Top 10’ Challenges for Health Technology Assessment: INAHTA ViewpointInternational Journal of Technology Assessment in Health Care, 2019
- Measurement Properties of Commonly Used Generic Preference-Based Measures in East and South-East Asia: A Systematic ReviewPharmacoEconomics, 2019
- Landscape analysis of health technology assessment (HTA): systems and practices in AsiaInternational Journal of Technology Assessment in Health Care, 2019
- A systematic review of the development and testing of additional dimensions for the EQ-5D descriptive systemExpert Review of Pharmacoeconomics & Outcomes Research, 2019
- Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force ReportValue in Health, 2019
- A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness ModelsPharmacoEconomics, 2017
- Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force ReportValue in Health, 2016
- HTA Implementation Roadmap in Central and Eastern European CountriesHealth Economics, 2016
- Qualitative and Mixed Methods Provide Unique Contributions to Outcomes ResearchCirculation, 2009